True North Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
5,229
+685
| +15% | +$47.9K | 0.07% | 159 |
|
|
2025
Q1 | $334K | Hold |
4,544
| – | – | 0.06% | 175 |
|
|
2024
Q4 | $298K | Buy |
+4,544
| New | +$298K | 0.07% | 149 |
|
|
2023
Q3 | – | Sell |
-5,507
| Closed | -$401K | – | 196 |
|
|
2023
Q2 | $401K | Sell |
5,507
-3,227
| -37% | -$235K | 0.11% | 133 |
|
|
2023
Q1 | $606K | Sell |
8,734
-4,366
| -33% | -$303K | 0.18% | 115 |
|
|
2022
Q4 | $888K | Hold |
13,100
| – | – | 0.3% | 80 |
|
|
2022
Q3 | $718K | Sell |
13,100
-79
| -0.6% | -$4.33K | 0.24% | 92 |
|
|
2022
Q2 | $870K | Buy |
13,179
+59
| +0.4% | +$3.9K | 0.27% | 85 |
|
|
2022
Q1 | $870K | Sell |
13,120
-75
| -0.6% | -$4.97K | 0.23% | 94 |
|
|
2021
Q4 | $768K | Sell |
13,195
-2,065
| -14% | -$120K | 0.13% | 124 |
|
|
2021
Q3 | $916K | Sell |
15,260
-27
| -0.2% | -$1.62K | 0.18% | 110 |
|
|
2021
Q2 | $915K | Hold |
15,287
| – | – | 0.19% | 100 |
|
|
2021
Q1 | $760K | Sell |
15,287
-62
| -0.4% | -$3.08K | 0.18% | 103 |
|
|
2020
Q4 | $767K | Hold |
15,349
| – | – | 0.2% | 95 |
|
|
2020
Q3 | $841K | Sell |
15,349
-486
| -3% | -$26.6K | 0.25% | 81 |
|
|
2020
Q2 | $837K | Buy |
+15,835
| New | +$837K | 0.2% | 85 |
|